Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection

PLoS Medicine

Volumn 3, Issue 12, 2006, Pages 2324-2334

  Kim, Arthur Y ^a   Zur Wiesch, Julian Schulze ^a,b   Kuntzen, Thomas ^a   Timm, Joerg ^a   Kaufmann, Daniel E ^a   Duncan, Jared E ^a   Jones, Andrea M ^a   Wurcel, Alysse G ^c   Davis, Benjamin T ^a   Gandhi, Rajesh T ^a   Robbins, Gregory K ^a   Allen, Todd M ^a   Chung, Raymond T ^a   Lauer, Georg M ^a   Walker, Bruce D ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c LEMUEL SHATTUCK HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ANTIGEN; GAG PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RESPONSIVE ELEMENT; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; T CELL DEPLETION; T LYMPHOCYTE; VIREMIA; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COMORBIDITY; CROSS-SECTIONAL STUDY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOASSAY; IMMUNOLOGY; LYMPHOCYTE COUNT; MULTICENTER STUDY; PHYSIOLOGY; RECURRENT DISEASE;

CD4-POSITIVE T-LYMPHOCYTES; COMORBIDITY; CROSS-SECTIONAL STUDIES; HEPACIVIRUS; HEPATITIS C; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNOASSAY; INTERFERON-GAMMA; LYMPHOCYTE COUNT; RECURRENCE; RNA, VIRAL; VIREMIA;

EID: 33845896269     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030492     Document Type: Article

References (37)

1. + T-cell response in acute hepatitis C [see comments]. Gastroenterology 117: 933-941.
2. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, et al. (2000) Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191: 1499-1512.
3. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, et al. (2001) Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 194: 1395-1406.
4. Takaki A, Wiese M, Maertens G, Depla E, Seifert U, et al. (2000) Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6: 578-582.
5. Sulkowski MS, Thomas DL (2003) Hepatitis C in the HIV-infected person. Ann Intern Med 138: 197-207.
6. + T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68: 8056-8063.
7. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, et al. (2003) HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
8. + T cells. J Exp Med 200: 701-712.
9. + T-cell count in individuals coinfected with HIV-1. Blood 105: 1170-1178.
10. Shoukry NH, Cawthon AG, Walker CM (2004) Cell-mediated immunity and the outcome of hepatitis C virus infection. Annu Rev Microbiol 58: 391-424.
11. + T lymphocytes in acute and chronic hepatitis C. J Mol Med 74: 583-588.
12. + T-cell responsiveness in hepatitis C virus infection. Hepatology 33: 267-276.
13. + T-helper-cell responses in resolved hepatitis C virus infection. J Virol 76: 12584-12595.
14. + Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes. J Immunol 175: 3603-3613.
15. Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, et al. (2002) Human immunodeficiency virus type 1-hepatitis C virus coinfection: Intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 76: 2817-2826.
16. Alatrakchi N, Martino VD, Thibault V, Autran B (2002) Strong CD4 Th1 responses to HIV and hepatitis C virus in HIV-infected long-term non-progressors co-infected with hepatitis C virus. AIDS 16: 713-717.
17. + T cells in HIV/HCV versus HCV. Hepatology 40: 125-132.
18. + cell depletion in hepatitis C virus/HIV-coinfected patients. J Acquir Immune Defic Syndr 37: 1125-1131.
19. Valdez H, Anthony D, Farukhi F, Patki A, Salkowitz J, et al. (2000) Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients. AIDS 14: 2239-2246.
20. Graham CS, Wells A, Liu T, Sherman KE, Peters M, et al. (2005) Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection. AIDS 19: 767-773.
21. + T cell responses associated with control of viremia [see comments]. Science 278: 1447-1450.
22. Lauer GM, Ouchi K, Chung RT, Nguyen TN, Day CL, et al. (2002) Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76: 6104-6113.
23. Lauer GM, Barnes E, Lucas M, Timm J, Ouchi K, et al. (2004) High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection. Gastroenterology 127: 924-936.
24. + T cell proliferation. Proc Natl Acad Sci U S A 98: 13878-13883.
25. Mehta SH, Cox A, Hoover DR, Wang XH, Mao Q, et al. (2002) Protection against persistence of hepatitis C. Lancet 359: 1478-1483.
26. Lee WM, Polson JE, Carney DS, Sahin B, Gale M Jr (2005) Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: Evidence for an occult viral reservoir. J Infect Dis 192: 1088-1092.
27. Diepolder HM, Zachoval R, Hoffmann RM, Wierenga EA, Santantonio T, et al. (1995) Possible mechanism involving T-lymphocyte response to nonstructural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 346: 1006-1007.
28. Dutoit V, Ciuffreda D, Comte D, Gonvers JJ, Pantaleo G (2005) Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. Eur J Immunol 35: 3493-3504.
29. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 4: 953-956.
30. Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, et al. (2002) Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99: 15661-15668.
31. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, et al. (2000) The natural history of hepatitis C virus infection: Host, viral, and environmental factors. JAMA 284: 450-456.
32. Piasecki BA, Lewis JD, Reddy KR, Bellamy SL, Porter SB, et al. (2004) Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a US veteran population. Hepatology 40: 892-899.
33. Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, et al. (2001) Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33: 1479-1487.
34. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, et al. (2006) Hepatitis C virus reinfection in injection drug users. Hepatology 44: 1139-1145.
35. + T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication. J Virol 76: 5925-5936.
36. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al. (2002) Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 169: 3447-3458.
37. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, et al. (2004) Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351: 438-450.